Evidence map›Paper›PMID 42460257›Full record

ArticlePrzeglad menopauzalny = Menopause review2026

Can machine learning predict endometrial cancer in patients with postmenopausal uterine bleeding?

Hadar Gluska, Nagam Gnaiem, Adi Ashkenazi Katz, Netanella Miller, Amit Tzidki, Alexandra Baron, Yael Hants, Mario Beiner, Aula Asali

Abstract read
In one paragraph

Article in Przeglad menopauzalny = Menopause review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hadar Gluska *Department of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Nagam Gnaiem *Department of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Adi Ashkenazi KatzSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Netanella MillerDepartment of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Amit TzidkiDepartment of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Alexandra BaronDepartment of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Yael HantsDepartment of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Mario BeinerDepartment of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.
Aula AsaliDepartment of Obstetrics and Gynaecology, Meir Medical Center, Kfar Saba, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Postmenopausal bleeding (PMB) is a common clinical symptom, with endometrial cancer (EC) accounting for about 10% of cases. This study aimed to develop machine-learning models to predict EC in women with PMB, supporting risk stratification and optimizing diagnostic pathways. Material and methods: We retrospectively analysed 617 women who underwent hysteroscopy for PMB at the Meir Medical Center between 2014 and 2023. Demographic, clinical, laboratory, and imaging data were collected. Three supervised machine-learning algorithms - Random Forest, eXtreme Gradient Boosting (XGBoost), and Light Gradient Boosting Machine (LightGBM) - were trained and evaluated. Synthetic minority oversampling technique addressed class imbalance. Model performance was assessed using accuracy, precision, recall, F1 score, and area under the receiver operating characteristic curve. Results: Seventy-two women (11.7%) were diagnosed with EC. eXtreme Gradient Boosting achieved the highest sensitivity (80%) for detecting EC, despite moderate accuracy (65%). Random Forest and LightGBM showed higher accuracy (85% and 84%, respectively) but much lower sensitivity. The most influential predictors in the XGBoost model were tamoxifen use, hormone therapy, age, hypertension, gravidity, parity, endometrial thickness, diabetes, and duration of bleeding. Conclusions: eXtreme Gradient Boosting provided the best clinical performance by minimizing missed diagnoses. Machine-learning models may enhance decision-making by identifying women at high risk for EC who require further evaluation. Larger datasets and additional clinical features are needed to improve specificity and reduce false positives.

Indexed as

endometrial cancergynaecologic oncologymachine learningpostmenopausal bleedingrisk predictionXGBoost

Identifiers

PMID42460257
PMCPMC13371689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.